Ticker Symbol: SNGX

Soligenix Inc

$0.90 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000812796

Company Profile

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: 29 Emmons Dr Ste B10

Website: www.soligenix.com

CEO: Christopher Schaber

Tags:

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $0.56

Change: $0.00 ( -1.46%)

Days Range: $0.56 - $0.59

Beta: -0.27

52wk. High: $10.93

52wk. Low: $0.42

Ytd. Change -92.94%

50 Day Moving Average: $0.52

200 Day Moving Average: $0.77

Shares Outstanding: 9841854

Valuation

Market Cap: 560.0M

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A